We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
5 hedge funds and large institutions have $457K invested in Plus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.04% → 0.02% (-0.02%)
44% less funds holding
Funds holding: 9 → 5 (-4)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
64% less capital invested
Capital invested by funds: $1.28M → $457K (-$822K)
Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$18.4K |
| 2 |
Bank of New York Mellon
New York
|
+$4.61K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$2.31K |